APGN
Income statement / Annual
Last year (2022), Apexigen, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Apexigen, Inc.'s net income was -$31.45 M.
See Apexigen, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
| Research and Development
Expenses |
$23.04 M
|
$21.66 M
|
$18.77 M
|
| General & Administrative
Expenses |
$9.65 M
|
$7.29 M
|
$5.77 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.65 M
|
$7.29 M
|
$5.77 M
|
| Other Expenses |
$617,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$32.69 M |
$28.96 M |
$24.54 M |
| Cost And Expenses |
$32.69 M |
$28.96 M |
$24.54 M |
| Interest Income |
$0.00 |
$41,000.00 |
$421,000.00 |
| Interest Expense |
-$617,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$110,000.00
|
$105,000.00
|
$127,000.00
|
| EBITDA |
-$32.58 M
|
-$28.85 M
|
-$24.42 M
|
| EBITDA Ratio |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$617,000.00
|
$41,000.00
|
$421,000.00
|
| Income Before Tax |
-$32.07 M |
-$28.92 M |
-$24.12 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
| Income Tax Expense |
-$617,000.00 |
-$41,000.00 |
-$421,000.00 |
| Net Income |
-$31.45 M |
-$28.88 M |
-$23.70 M |
| Net Income Ratio |
0 |
0 |
0 |
| EPS |
-1.59 |
-0.93 |
-0.76 |
| EPS Diluted |
-1.59 |
-0.93 |
-0.76 |
| Weighted Average Shares
Out |
$19.79 M
|
$31.07 M
|
$31.07 M
|
| Weighted Average Shares
Out Diluted |
$19.79 M
|
$31.07 M
|
$31.07 M
|
| Link |
|
|
|
